4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001996325-26-000002
Options or other derivatives
- EVP, Chief Commercial Officer acquired 126,440 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Garner Thomas EVP, Chief Commercial Officer | 2026-03-06 | Grant or award · Stock Option (Right to Buy) | +97,947 | 97,947 | D | ||
| Garner Thomas EVP, Chief Commercial Officer | 2026-03-06 | Grant or award · Restricted Stock Units | +28,493 | 28,493 | D | ||
Loading xslF345X05/form4-03102026_060309.xml…